Crypto News1 MIN READ
CRYPTONEUTRAL
AbCellera (ABCL) Shares Climb 6% Following Phase 2 Data Release for Menopause Treatment
FG
FOMOGRAM Editorial Desk
Aug 8, 2026
EXECUTIVE SUMMARY
AbCellera (ABCL) shares increased by 6% after the release of Q2 earnings and the announcement of Phase 2 data for the non-hormonal menopause treatment ABCL635, scheduled for August 10, 2026.
AbCellera (ABCL) shares increased by 6% after the release of Q2 earnings and the announcement of Phase 2 data for the non-hormonal menopause treatment ABCL635, scheduled for August 10, 2026.
FOMOGRAM SENTINEL GRAVITY TELEMETRY
General news unrelated to monitored cryptocurrencies.
BTC OVERALL MARKET INDEX: 62 / 100 (BULLISH)
Explore all verified news, research, and global sources for CRYPTO.